NEW ORLEANS, Sept. 26, 2014 /PRNewswire/ -- Former Attorney
General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of
Kahn Swick & Foti, LLC ("KSF") are investigating the proposed
sale of LipoScience, Inc. ("LipoScience" or the "Company") (NASDAQ:
LPDX) to Laboratory Corporation of America Holdings (NYSE: LH).
Under the terms of the proposed transaction,
shareholders of LipoScience will receive only $5.25 in cash for each share of LipoScience
common stock that they own. KSF is seeking to determine
whether this consideration and the process that led to it are
adequate, or whether the consideration undervalues the Company.
If you believe that this transaction undervalues the Company
and/or if you would like to discuss your legal rights regarding the
proposed sale, you may, without obligation or cost to you, e-mail
or call KSF Managing Partner Lewis S. Kahn
(lewis.kahn@ksfcounsel.com) or associate Michael J. Palestina
(michael.palestina@ksfcounsel.com) toll free at any time at
855-768-1857.
To learn more about KSF, whose partners include the Former
Louisiana Attorney General, visit www.ksfcounsel.com.
Kahn Swick & Foti, LLC
206 Covington St.
Madisonville, LA 70447
SOURCE Kahn Swick & Foti, LLC